Streptococcus pneumoniae: Drug Resistance and Optimal Therapeutic Approaches

Streptococcus pneumoniae accounts for millions of infectious deaths annually. It is the most common bacterial cause of community-acquired pneumonia, especially among "at-risk" patients such as those with chronic obstructive pulmonary disease (COPD), diabetes, over 50 years of age, or who have been exposed to a nursing home or daycare facility environment. Antimicrobial resistance among S. pneumoniae has increased globally in the last 30 years, …